RepSox: A Potent and Selective ALK5 Inhibitor for TGF-β Pathway Research

Executive Summary: RepSox (2-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine) is a potent and selective ALK5 (TGFβR-1) inhibitor with an IC₅₀ of 4 nM, enabling precise inhibition of TGF-β/Smad signaling (APExBIO). It is widely used in induced pluripotent stem cell (iPSC) reprogramming, where it can replace Sox2 function and induce Nanog expression in mouse embryonic fibroblasts (MEFs) (Ichida et al., 2009, Cell). RepSox is DMSO- and ethanol-soluble but insoluble in water, and is typically applied at 25 μM for 3 days in cell culture. Its use facilitates high-efficiency cell differentiation and cost-effective platelet production from iPSCs (Yue et al., 2026). RepSox is for research use only and is distributed by APExBIO.

Biological Rationale

The TGF-β signaling pathway plays a central role in regulating cell proliferation, differentiation, and tumor transformation (Massagué 2012, Nature Reviews Molecular Cell Biology). ALK5 (TGFβR-1) is a serine/threonine kinase acting as a key receptor in this pathway. Aberrant TGF-β signaling is implicated in cancer progression, fibrosis, and cell proliferation disorders (PMID: 29262674). Inhibiting ALK5 allows researchers to dissect TGF-β-mediated regulation and to unlock reprogramming potential in somatic cells. RepSox has emerged as a preferred small molecule tool for these applications due to its high potency and selectivity for TGFβR-1, enabling reproducible control over downstream gene expression and cellular fate (APExBIO).

Mechanism of Action of RepSox (ALK5 inhibitor, potent and selective)

RepSox selectively inhibits the TGF-β type I receptor ALK5 with an IC₅₀ of 4 nM, blocking phosphorylation of downstream Smad2/3 proteins (Cell, Ichida et al., 2009). This action suppresses canonical TGF-β signaling, leading to derepression of genes such as Id1, Id2, and Id3. In the context of cell reprogramming, RepSox can substitute for Sox2 by inducing Nanog expression, thereby promoting pluripotency in MEFs. The compound also increases L-Myc expression fivefold in treated cells, further supporting reprogramming efficiency. RepSox is chemically defined as 2-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine (molecular weight: 287.32, CAS: 446859-33-2).

Evidence & Benchmarks

• RepSox inhibits ALK5 (TGFβR-1) with an IC₅₀ of 4 nM, demonstrating high potency for TGF-β pathway suppression (APExBIO).
• RepSox replaces Sox2 in iPSC reprogramming, inducing Nanog expression and enabling generation of fully pluripotent iPSCs from MEFs (Ichida et al., 2009, Cell).
• In RepSox-treated MEFs, L-Myc expression increases fivefold, aiding in efficient reprogramming (Cell).
• iPSCs generated with RepSox contribute to mosaic embryos and adult mice in vivo, confirming biological activity (Ichida et al., 2009, Cell).
• Optimized iPSC-to-platelet protocols using TGF-β pathway inhibitors similar to RepSox reduce differentiation costs by 58.3% and increase yield to 14.9 functional platelets per iPSC (Yue et al., 2026, Stem Cell Reviews and Reports).
• RepSox's selectivity minimizes off-target effects compared to non-selective kinase inhibitors (APExBIO).
• For iPSC reprogramming, a 25 μM RepSox treatment for 3 days in culture is standard (APExBIO).

For further mechanistic insights, see RepSox: A Selective TGFβR-1 Inhibitor Powering iPSC Differentiation—this article extends those findings with updated benchmarks and cost analyses from 2026.

For a translational perspective, RepSox and the Next Frontier in iPSC-Derived Platelet Production covers broader clinical implications, while the current article provides granular, protocol-level details and quantitative comparisons.

Applications, Limits & Misconceptions

RepSox is primarily used for:

• Induced pluripotent stem cell (iPSC) reprogramming.
• Suppression of TGF-β/Smad-mediated gene repression in cancer and fibrosis research.
• Facilitation of megakaryocyte maturation and high-yield platelet production from pluripotent cells.
• Dissection of TGF-β signaling in cell proliferation and transformation studies.

Common Pitfalls or Misconceptions

• RepSox is not effective in water-based media due to insolubility; use DMSO or ethanol as solvents (APExBIO).
• Long-term storage of RepSox in solution is not recommended; stability is compromised beyond short-term use.
• RepSox is not intended for diagnostic or therapeutic use in humans or animals.
• It does not substitute for all TGF-β pathway inhibitors; selectivity for ALK5 is crucial for its effects.
• Overdosing (above recommended 25 μM) may cause off-target effects or toxicity in certain cell types.

Workflow Integration & Parameters

RepSox (A3754, APExBIO) is supplied as a chemically-defined powder. For routine cell biology workflows:

• Preparation: Dissolve RepSox in DMSO (≥14.35 mg/mL) or ethanol (≥47.9 mg/mL, with gentle warming).
• Storage: Store dry aliquots at -20°C. Use solutions promptly after preparation.
• Experimental Use: Typical concentration is 25 μM for 3 days in cell culture, especially for iPSC reprogramming (APExBIO).
• Applications: Combine with Oct4, Klf4, and cMyc for reprogramming; apply to MEFs or other somatic cells for direct conversion protocols (Yue et al., 2026).
• Quality Control: Confirm ALK5 inhibition via Smad2/3 phosphorylation assays.

Detailed protocols and troubleshooting tips are available on the RepSox (ALK5 inhibitor, potent and selective) product page.

Conclusion & Outlook

RepSox is a validated and versatile research tool for selective inhibition of the TGF-β type I receptor (ALK5). Its impact on iPSC reprogramming and cost-effective, high-yield platelet production is supported by multiple peer-reviewed studies (Yue et al., 2026; Ichida et al., 2009). RepSox enables rigorous mechanistic studies in cancer, stem cell biology, and regenerative medicine, with robust benchmarks for experimental design. As the field advances, RepSox's integration into optimized workflows offers new avenues for translational applications, while its selectivity minimizes off-target effects. For further details, see the A3754 kit from APExBIO and recent protocol updates in the literature.